CLINTREX METHOD
Dead / Cancelled — Cancelled — Section 7 (surrendered) (as of 30 Sept 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85905970
- Registration number
- 4561241
- Mark type
- Stylized text
- Filed
- 16 Apr 2013
- Published for opposition
- 24 Sept 2013
- Registered
- 01 Jul 2014
- Attorney of record
- Jeremy P. Oczek
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
- Class 042 — Scientific and technological services: Conducting clinical trials for others in the field of neurodegenerative disorders
Owner
- Clintrex, LLC, Rye, NY, US
- Clintrex, LLC, Rye, NY, US
- Clintrex, LLC, Rye, NY, US
Prosecution history
- 01 Oct 2020 — NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
- 30 Sept 2020 — CANCELLED SECTION 7-TOTAL
- 23 Sept 2020 — REQUEST FOR SECT 7 TOTAL SURRENDER FILED
- 30 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Sept 2020 — TEAS SECTION 7 SURRENDER RECEIVED
- 01 Jul 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jan 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Jul 2014 — REGISTERED-PRINCIPAL REGISTER
- 28 May 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 May 2014 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 27 May 2014 — ASSIGNED TO LIE
- 26 May 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 May 2014 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Apr 2014 — USE AMENDMENT FILED
- 29 Apr 2014 — CASE ASSIGNED TO INTENT TO USE PARALEGAL